ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group

Leukemia Research

Volumn 37, Issue 8, 2013, Pages 936-942

  Linabery, Amy M ^a   Blommer, Crystal N ^b   Spector, Logan G ^a,b   Davies, Stella M ^c   Robison, Leslie L ^d   Ross, Julie A ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Acute lymphoblastic leukemia; Children; Gene environment interaction; Genetic susceptibility

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARID5B GENE; ARTICLE; B LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA; B LINEAGE HYPERDIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA; BIRTH WEIGHT; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IKZF1 GENE; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; BIRTH WEIGHT; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IKAROS TRANSCRIPTION FACTOR; INFANT; LOGISTIC MODELS; MALE; MATERNAL AGE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84879787113     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.04.022     Document Type: Article

References (38)

1. Linabery A.M., Ross J.A. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008, 112:416-432.
2. Pizzo P.A., Poplack D.G. Principles and practice of pediatric oncology 2011, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA. 6th ed.
3. Wakeford R., Little M.P. Risk coefficients for childhood cancer after intrauterine irradiation: a review. Int J Radiat Biol 2003, 79:293-309.
4. Caughey R.W., Michels K.B. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer 2009, 124:2658-2670.
5. Johnson K.J., Carozza S.E., Chow E.J., Fox E.E., Horel S., McLaughlin C.C., et al. Parental age and risk of childhood cancer: a pooled analysis. Epidemiology 2009, 20:475-483.
6. Trevino L.R., Yang W., French D., Hunger S.P., Carroll W.L., Devidas M., et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009, 41:1001-1005.
7. Papaemmanuil E., Hosking F.J., Vijayakrishnan J., Price A., Olver B., Sheridan E., et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009, 41:1006-1010.
8. Prasad R.B., Hosking F.J., Vijayakrishnan J., Papaemmanuil E., Koehler R., Greaves M., et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010, 115:1765-1767.
9. Healy J., Richer C., Bourgey M., Kritikou E.A., Sinnett D. Replication analysis confirms the association of ARID5B with childhood B-cell acute lymphoblastic leukemia. Haematologica 2010, 95:1608-1611.
10. Yang W., Trevino L.R., Yang J.J., Scheet P., Pui C.H., Evans W.E., et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia 2010, 24:894-896.
11. Vijayakrishnan J., Sherborne A.L., Sawangpanich R., Hongeng S., Houlston R.S., Pakakasama S. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence. Leuk Lymphoma 2010, 51:1870-1874.
12. Han S., Lee K.M., Park S.K., Lee J.E., Ahn H.S., Shin H.Y., et al. Genome-wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res 2010, 34:1271-1274.
13. Pastorczak A., Gorniak P., Sherborne A., Hosking F., Trelinska J., Lejman M., et al. Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population. Leuk Res 2011, 35:1534-1536.
14. Xu H., Cheng C., Devidas M., Pei D., Fan Y., Yang W., et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol 2012, 30:751-757.
15. Ellinghaus E., Stanulla M., Richter G., Ellinghaus D., Te Kronnie G., Cario G., et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia 2012, 26:902-909.
16. Orsi L., Rudant J., Bonaventure A., Goujon-Bellec S., Corda E., Evans T.J., et al. Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE). Leukemia 2012, 26:2561-2564.
17. Ross J.A., Linabery A.M., Blommer C.N., Langer E.K., Spector L.G., Hilden J.M., et al. Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report. Pediatr Blood Cancer 2013, 60:31-34.
18. Peyrouze P., Guihard S., Grardel N., Berthon C., Pottier N., Pigneux A., et al. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study. Br J Haematol 2012, 159:599-602.
19. Rudant J., Orsi L., Bonaventure A., Goujon-Bellec S., Corda E., Baruchel A., et al. Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)?. Leukemia 2012, [Epub ahead of print]. 10.1038/leu.2012.244.
20. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994, 79:143-156.
21. Sellars M., Kastner P., Chan S. Ikaros in B cell development and function. World J Biol Chem 2011, 2:132-139.
22. Lahoud M.H., Ristevski S., Venter D.J., Jermiin L.S., Bertoncello I., Zavarsek S., et al. Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 2001, 11:1327-1334.
23. Mullighan C.G., Miller C.B., Radtke I., Phillips L.A., Dalton J., Ma J., et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008, 453:110-114.
24. Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B., et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009, 360:470-480.
25. Paulsson K., Forestier E., Lilljebjorn H., Heldrup J., Behrendtz M., Young B.D., et al. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Proc Natl Acad Sci USA 2010, 107:21719-21724.
26. Brondum J., Shu X.O., Steinbuch M., Severson R.K., Potter J.D., Robison L.L. Parental cigarette smoking and the risk of acute leukemia in children. Cancer 1999, 85:1380-1388.
27. Shu X.O., Perentesis J.P., Wen W., Buckley J.D., Boyle E., Ross J.A., et al. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Cancer Epidemiol Biomarkers Prev 2004, 13:1230-1235.
28. Boyle E.B., Steinbuch M., Tekautz T., Gutman J.R., Robison L.L., Perentesis J.P. Accuracy of DNA amplification from archival hematological slides for use in genetic biomarker studies. Cancer Epidemiol Biomarkers Prev 1998, 7:1127-1131.
29. Gauderman WJ, Morrison JM. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies, ; 2006. http://hydra.usc.edu/gxe.
30. Papathanasiou P., Attema J.L., Karsunky H., Hosen N., Sontani Y., Hoyne G.F., et al. Self-renewal of the long-term reconstituting subset of hematopoietic stem cells is regulated by Ikaros. Stem Cells 2009, 27:3082-3092.
31. Johnson A.D., Handsaker R.E., Pulit S.L., Nizzari M.M., O'Donnell C.J., de Bakker P.I. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008, 24:2938-2939.
32. Virely C., Moulin S., Cobaleda C., Lasgi C., Alberdi A., Soulier J., et al. Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia. Leukemia 2010, 24:1200-1204.
33. Kastner P., Chan S. Role of Ikaros in T-cell acute lymphoblastic leukemia. World J Biol Chem 2011, 2:108-114.
34. Payne K.J., Dovat S. Ikaros and tumor suppression in acute lymphoblastic leukemia. Crit Rev Oncog 2011, 16:3-12.
35. Surveillance, Epidemiology and End Results (SEER) Program SEERz.ast;Stat Database: Incidence - SEER 13 Regs Research Data, Nov 2011 Sub, Vintage 2009 Pops (1992-2009) - Linked To County Attributes - Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission; 2012 [accessed October 16, 2012]. http://www.seer.cancer.gov/.
36. Borkhardt A., Wuchter C., Viehmann S., Pils S., Teigler-Schlegel A., Stanulla M., et al. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 2002, 16:1685-1690.
37. Jansen M.W., Corral L., van der Velden V.H., Panzer-Grumayer R., Schrappe M., Schrauder A., et al. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 2007, 21:633-641.
38. Olson J.E., Shu X.O., Ross J.A., Pendergrass T., Robison L.L. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol 1997, 145:58-67.